Clinical Trial Update: Pacritinib For Bone Marrow Fibrosis In Patients With Myelofibrosis Who Have Thrombocytopenia [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating pacritinib for bone marrow fibrosis in patients with myelofibrosis who have thrombocytopenia; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Pacritinib (pacritinib)

Snippet

Sponsor: Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas | Conditions: Myelofibrosis，MF | Phase 2 | Status: NOT_YET_RECRUITING